Cargando…

Multisystemic Impairments in 93 Chinese Patients With Myotonic Dystrophy Type 1

Background: Myotonic dystrophy type 1 (DM1) is an autosomal dominant neuromuscular disease characterized by muscle weakness and multisystemic impairments, which significantly impact the quality of life. There is currently an increasing consensus on the necessity of a multidisciplinary assessment in...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Mao, Wang, Zhanjun, Cui, Fang, Yang, Fei, Wang, Hongfen, Huang, Xusheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186325/
https://www.ncbi.nlm.nih.gov/pubmed/32373051
http://dx.doi.org/10.3389/fneur.2020.00277
_version_ 1783526922233315328
author Li, Mao
Wang, Zhanjun
Cui, Fang
Yang, Fei
Wang, Hongfen
Huang, Xusheng
author_facet Li, Mao
Wang, Zhanjun
Cui, Fang
Yang, Fei
Wang, Hongfen
Huang, Xusheng
author_sort Li, Mao
collection PubMed
description Background: Myotonic dystrophy type 1 (DM1) is an autosomal dominant neuromuscular disease characterized by muscle weakness and multisystemic impairments, which significantly impact the quality of life. There is currently an increasing consensus on the necessity of a multidisciplinary assessment in patients with DM1, to improve the management of the disease. Methods: To analyze the prevalence and pairwise relationships between various organs involved, we performed a retrospective study by reviewing demographic and clinical information of DM1 patients including age, disease duration, clinical history, muscular impairment rating scale score (MIRS), results of blood biochemistry, electrocardiogram, echocardiography, and ophthalmologic examination. Results: Ninety three DM1 patients (60 males and 33 females), aged 34.7 ± 12.6 (mean ± standard deviation) years were recruited. Of which, two congenital cases were of maternal and paternal inheritance, respectively. In the other 91 patients, cataract was found in 44.1% of patients, followed by hypogonadism (40.8%), frontal balding (40.7%), and cardiac abnormalities (34.5%). Thyroid dysfunction and insulin insensitivity were relatively uncommon. Age (p < 0.001) is independently correlated with cataract, and MIRS correlates positively with cardiac abnormalities (p = 0.005) and frontal balding (p = 0.015). Male patients more frequently had frontal balding (Risk ratio, 3.98; 95% confidence interval, 1.493–10.611) compared with female patients. Male patients with cataract presented more frequent cardiac abnormalities (Risk ratio, 4.40; 95% confidence interval, 1.055–18.358) compared with non-cataract male patients. Hypogonadism in male patients was characterized as decreased testosterone level, accompanied by elevated levels of luteinizing hormone and follicle-stimulating hormone. Conclusions: In Chinese patients with DM1, we conclude that (1) cataract, hypogonadism, frontal balding and cardiac abnormalities are frequently observed; (2) age is an independent indicator to cataract and MIRS is the only predictor for cardiac abnormalities and frontal balding; (3) a positive correlation between ophthalmologic and cardiac impairments in male patients is found; (4) endocrine abnormalities show diverse manifestations and hormone tests are recommended; (5) particular attention should be given to patients with older age and higher MIRS score.
format Online
Article
Text
id pubmed-7186325
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-71863252020-05-05 Multisystemic Impairments in 93 Chinese Patients With Myotonic Dystrophy Type 1 Li, Mao Wang, Zhanjun Cui, Fang Yang, Fei Wang, Hongfen Huang, Xusheng Front Neurol Neurology Background: Myotonic dystrophy type 1 (DM1) is an autosomal dominant neuromuscular disease characterized by muscle weakness and multisystemic impairments, which significantly impact the quality of life. There is currently an increasing consensus on the necessity of a multidisciplinary assessment in patients with DM1, to improve the management of the disease. Methods: To analyze the prevalence and pairwise relationships between various organs involved, we performed a retrospective study by reviewing demographic and clinical information of DM1 patients including age, disease duration, clinical history, muscular impairment rating scale score (MIRS), results of blood biochemistry, electrocardiogram, echocardiography, and ophthalmologic examination. Results: Ninety three DM1 patients (60 males and 33 females), aged 34.7 ± 12.6 (mean ± standard deviation) years were recruited. Of which, two congenital cases were of maternal and paternal inheritance, respectively. In the other 91 patients, cataract was found in 44.1% of patients, followed by hypogonadism (40.8%), frontal balding (40.7%), and cardiac abnormalities (34.5%). Thyroid dysfunction and insulin insensitivity were relatively uncommon. Age (p < 0.001) is independently correlated with cataract, and MIRS correlates positively with cardiac abnormalities (p = 0.005) and frontal balding (p = 0.015). Male patients more frequently had frontal balding (Risk ratio, 3.98; 95% confidence interval, 1.493–10.611) compared with female patients. Male patients with cataract presented more frequent cardiac abnormalities (Risk ratio, 4.40; 95% confidence interval, 1.055–18.358) compared with non-cataract male patients. Hypogonadism in male patients was characterized as decreased testosterone level, accompanied by elevated levels of luteinizing hormone and follicle-stimulating hormone. Conclusions: In Chinese patients with DM1, we conclude that (1) cataract, hypogonadism, frontal balding and cardiac abnormalities are frequently observed; (2) age is an independent indicator to cataract and MIRS is the only predictor for cardiac abnormalities and frontal balding; (3) a positive correlation between ophthalmologic and cardiac impairments in male patients is found; (4) endocrine abnormalities show diverse manifestations and hormone tests are recommended; (5) particular attention should be given to patients with older age and higher MIRS score. Frontiers Media S.A. 2020-04-21 /pmc/articles/PMC7186325/ /pubmed/32373051 http://dx.doi.org/10.3389/fneur.2020.00277 Text en Copyright © 2020 Li, Wang, Cui, Yang, Wang and Huang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Li, Mao
Wang, Zhanjun
Cui, Fang
Yang, Fei
Wang, Hongfen
Huang, Xusheng
Multisystemic Impairments in 93 Chinese Patients With Myotonic Dystrophy Type 1
title Multisystemic Impairments in 93 Chinese Patients With Myotonic Dystrophy Type 1
title_full Multisystemic Impairments in 93 Chinese Patients With Myotonic Dystrophy Type 1
title_fullStr Multisystemic Impairments in 93 Chinese Patients With Myotonic Dystrophy Type 1
title_full_unstemmed Multisystemic Impairments in 93 Chinese Patients With Myotonic Dystrophy Type 1
title_short Multisystemic Impairments in 93 Chinese Patients With Myotonic Dystrophy Type 1
title_sort multisystemic impairments in 93 chinese patients with myotonic dystrophy type 1
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186325/
https://www.ncbi.nlm.nih.gov/pubmed/32373051
http://dx.doi.org/10.3389/fneur.2020.00277
work_keys_str_mv AT limao multisystemicimpairmentsin93chinesepatientswithmyotonicdystrophytype1
AT wangzhanjun multisystemicimpairmentsin93chinesepatientswithmyotonicdystrophytype1
AT cuifang multisystemicimpairmentsin93chinesepatientswithmyotonicdystrophytype1
AT yangfei multisystemicimpairmentsin93chinesepatientswithmyotonicdystrophytype1
AT wanghongfen multisystemicimpairmentsin93chinesepatientswithmyotonicdystrophytype1
AT huangxusheng multisystemicimpairmentsin93chinesepatientswithmyotonicdystrophytype1